Akbarali HI, Muchhala KH, Jessup DK, Cheatham S. Chemotherapy induced gastrointestinal toxicities. Adv Cancer Res. 2022;155:131-166. doi:10.1016/bs.acr.2022.02.007
Bonis PA & Lamont JT. Approach to the adult with chronic diarrhea in resource-abundant settings. UpToDate. UpToDate Inc; 2023. Updated May 2022. Accessed December 19, 2023. https://www.uptodate.com/contents/approach-to-the-adult-with-chronic-diarrhea-in-resource-abundant-settings
Grover S, Wang Y, & Dougan M. Immune checkpoint inhibitor colitis. UpToDate. UpToDate Inc; 2023. Updated May 2023. Accessed December 19, 2023. https://www.uptodate.com/contents/immune-checkpoint-inhibitor-colitis
Krishnamurthi SS and Macaron C. Management of acute chemotherapy-related diarrhea. UpToDate. UpToDate Inc; 2023. Updated December 2022. Accessed December 19, 2023. https://www.uptodate.com/contents/management-of-acute-chemotherapy-related-diarrhea
Krishnamurthi SS and Kamath SK. Chemotherapy-associated diarrhea, constipation, and intestinal perforation: pathogenesis, risk factors, and clinical presentation. UpToDate. UpToDate Inc; 2023. Updated November 2023. Accessed December 19, 2023. https://www.uptodate.com/contents/chemotherapy-associated-diarrhea-constipation-and-intestinal-perforation-pathogenesis-risk-factors-and-clinical-presentation
Lamont JT, Bakken JS, and Kelly CP. Clostridioides difficile infection in adults: Epidemiology, microbiology, and pathophysiology. UpToDate. UpToDate Inc; 2023. Updated January 2023. Accessed December 19, 2023. https://www.uptodate.com/contents/clostridioides-difficile-infection-in-adults-epidemiology-microbiology-and-pathophysiology
Nielsen DL, Juhl CB, Chen IM, Kellermann L, Nielsen OH. Immune checkpoint Inhibitor-Induced diarrhea and Colitis: Incidence and Management. A systematic review and Meta-analysis. Cancer Treat Rev. 2022;109:102440. doi:10.1016/j.ctrv.2022.102440